리바비린

리바비린
체계적 명칭 (IUPAC 명명법)
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
식별 정보
CAS 등록번호36791-04-5
ATC 코드AB04
PubChem37542
드러그뱅크DB00811
ChemSpider34439
화학적 성질
화학식C8H12N4O5 
분자량244.206
SMILESeMolecules & PubChem
유의어1-(β-D-Ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide
약동학 정보
생체적합성45% oral (without food), about 76% with fatty meal
약물 대사Metabolized to 5'phosphates, de-riboside, and deriboside carboxylic acid
생물학적 반감기12 days - Multiple Dose; 120-170 hours - Single Dose
배출10% fecal, remainder in urine (30% unchanged, remainder metabolites)
처방 주의사항
임부투여안전성US: X; AU: X
법적 지위Ethical U.S. pharmaceutical; Not DEA-controlled.
투여 방법Liquid for inhalation; oral capsule and tablet

리바비린(ribavirin)항바이러스제이다. 주로 C형 간염 치료에 쓰인다.

En otros idiomas
العربية: ريبافيرين
تۆرکجه: ریباویرین
Cymraeg: Ribafirin
Deutsch: Ribavirin
English: Ribavirin
español: Ribavirina
فارسی: ریباویرین
français: Ribavirine
Bahasa Indonesia: Ribavirin
italiano: Ribavirina
日本語: リバビリン
монгол: Рибавирин
polski: Rybawiryna
português: Ribavirina
русский: Рибавирин
srpskohrvatski / српскохрватски: Ribavirin
slovenščina: Ribavirin
српски / srpski: Ribavirin
Türkçe: Ribavirin
українська: Рибавірин
Tiếng Việt: Ribavirin
中文: 利巴韦林
粵語: 利巴韋林